Fundraising Fox
Primex Pharmaceuticals Oy
2 known investors
Find your way into Primex Pharmaceuticals Oy
Sign up to see every warm intro you have to Primex Pharmaceuticals Oy
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Primex Pharmaceuticals Oy team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Primex Pharmaceuticals owns and markets specialty anaesthetic pharmaceuticals for perioperative therapy on a global basis. The company acquires rights to established drug candidates and manages regulatory affairs and distribution without conducting internal R&D or manufacturing.
Founders & leadership
JM
Jany MengelkampBoard Member & Co-FounderJany Mengelkamp is board member and co-founder of Primex Pharmaceuticals, which acquires and markets specialty anesthetic drugs for perioperative use globally. He brings experience from the pharmaceutical and management consulting sectors, with expertise in business development and international business strategy.
Investors · 2
In the news
Frequently asked questions
- What does Primex Pharmaceuticals Oy do?
- Primex Pharmaceuticals owns and markets specialty anaesthetic pharmaceuticals for perioperative therapy on a global basis. The company acquires rights to established drug candidates and manages regulatory affairs and distribution without conducting internal R&D or manufacturing.
- Who founded Primex Pharmaceuticals Oy?
- Primex Pharmaceuticals Oy was founded by Jany Mengelkamp.
- Who are Primex Pharmaceuticals Oy's investors?
- Primex Pharmaceuticals Oy's investors include Innovestor Ventures, Tesi (Finnish Industry Investment Ltd).